APA (7th ed.) Citation

E, M., M, W., R, H., MV, Z., A, P., SS, S., . . . SK, G. (2026). Incidence, risk factors, and cardiovascular impact of hypertension in people with HIV: A secondary analysis of the REPRIEVE trial. The lancet. HIV, 13(5), e327. https://doi.org/10.1016/S2352-3018(26)00036-6

Chicago Style (17th ed.) Citation

E, Martínez, et al. "Incidence, Risk Factors, and Cardiovascular Impact of Hypertension in People with HIV: A Secondary Analysis of the REPRIEVE Trial." The Lancet. HIV 13, no. 5 (2026): e327. https://doi.org/10.1016/S2352-3018(26)00036-6.

MLA (9th ed.) Citation

E, Martínez, et al. "Incidence, Risk Factors, and Cardiovascular Impact of Hypertension in People with HIV: A Secondary Analysis of the REPRIEVE Trial." The Lancet. HIV, vol. 13, no. 5, 2026, p. e327, https://doi.org/10.1016/S2352-3018(26)00036-6.